BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 20, 2013
View Archived Issues
A report on the discovery of a novel host-specific biomarker for river blindness
Read More
Venaxis enters commercial development agreements for its appendicitis test
Read More
FDA grants 6-month pediatric exclusivity to Hospira's Precedex injection
Read More
FDA grants fast track status to TransTech Pharma's TTP-488
Read More
Addex receives Michael J. Fox Foundation grant for dipraglurant
Read More
Boehringer Ingelheim and Lilly commence MARLINA trial
Read More
Initial results from phase II BOLD extension study of siponimod presented
Read More
Acumen Pharmaceuticals describes antibody that binds soluble beta-amyloid oligomers
Read More
Italian and U.S. scientists divulge novel FAAH inhibitors
Read More
Targacept identifies anti-inflammatory therapeutics
Read More
InSite Vision reports phase III BromSite data
Read More
Merck Serono and Bristol-Myers Squibb to promote Glucophage in China
Read More
Novel ciclosporin derivatives described
Read More
Trevena reports first-in-human data on TRV-130
Read More
NPS Pharmaceuticals regains rights to teduglutide and PTH 1-84
Read More
Pharmaxis receives FDA complete response letter for Bronchitol
Read More
Canadian researchers patent new cancer diagnostics
Read More
Novel tyrosine kinase inhibitors patented
Read More
HLA-A-based peptide immunotherapies under investigation for prostate cancer
Read More
Affymetrix QuantiGene Technology used to assess microRNA 122 as hepatotoxicity biomarker
Read More
Pharmacokinetic evaluation of a novel intrathecal-lumbar formulation of idursulfase
Read More
Biocancell's phase IIb trial in bladder cancer meets primary endpoint
Read More
EGEN initiates phase I trial in recurrent ovarian cancer
Read More
Phase III study of Amgen's talimogene laherparepvec meets primary endpoint
Read More
AstraZeneca reports plans to restructure its global R&D operations
Read More
